Category: Reagents

Active filters

CD 437

Reference: B6785-25

RARγ-selective agonist,potent and cell-permeable

SU 4312

Reference: 20213-1

A selective inhibitor of VEGFR2 and PDGFR tyrosine kinases (IC50s = 0.8 and 19.4 μM, respectively); inhibits VEGF-dependent angiogenesis in a zebrafish assay (IC50 = 1.8 µM) without affecting normal cells; neuroprotective

CD 437

Reference: B6785-50

RARγ-selective agonist,potent and cell-permeable

SU 4312

Reference: 20213-10

A selective inhibitor of VEGFR2 and PDGFR tyrosine kinases (IC50s = 0.8 and 19.4 μM, respectively); inhibits VEGF-dependent angiogenesis in a zebrafish assay (IC50 = 1.8 µM) without affecting normal cells; neuroprotective

CD 437

Reference: B6785-100

RARγ-selective agonist,potent and cell-permeable

SU 4312

Reference: 20213-25

A selective inhibitor of VEGFR2 and PDGFR tyrosine kinases (IC50s = 0.8 and 19.4 μM, respectively); inhibits VEGF-dependent angiogenesis in a zebrafish assay (IC50 = 1.8 µM) without affecting normal cells; neuroprotective

SC 560

Reference: B6786-5

COX-1-selective inhibitor

SU 4312

Reference: 20213-5

A selective inhibitor of VEGFR2 and PDGFR tyrosine kinases (IC50s = 0.8 and 19.4 μM, respectively); inhibits VEGF-dependent angiogenesis in a zebrafish assay (IC50 = 1.8 µM) without affecting normal cells; neuroprotective

SC 560

Reference: B6786-5.1

COX-1-selective inhibitor

BRD7389

Reference: 20214-1

An inhibitor of RSKs (IC50s = 1.5, 2.4, and 1.2 μM for RSK1, RSK2, and RSK3, respectively); causes mouse αTC1 pancreatic α cells to adopt several morphological and gene expression features of β cells, including increased insulin expression

SC 560

Reference: B6786-10

COX-1-selective inhibitor

BRD7389

Reference: 20214-10

An inhibitor of RSKs (IC50s = 1.5, 2.4, and 1.2 μM for RSK1, RSK2, and RSK3, respectively); causes mouse αTC1 pancreatic α cells to adopt several morphological and gene expression features of β cells, including increased insulin expression

Back to top